Oramed Pharmaceuticals Inc. SEC filings ORMP
Oramed Pharmaceuticals Inc. has 941 filings in SEC EDGAR's recent list, going back to Nov 29, 2002. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 4 | Insider transaction | Sep 25, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 25, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 25, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 25, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 17, 2026 | Sep 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| ARS | Annual report to shareholders | Aug 3, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Aug 3, 2026 | — |
| DEF 14A | Proxy statement | Aug 3, 2026 | Sep 15, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 22, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jun 30, 2026 | Jun 25, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 29, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 17, 2026 | — |
| 10-Q | Quarterly report | May 19, 2026 | Mar 31, 2026 |
| NT 10-Q | Notification of late filing | May 15, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 3 | Initial insider ownership | May 14, 2026 | Mar 25, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | May 14, 2026 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Mar 31, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 31, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Mar 31, 2026 | Mar 30, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Material agreement
|
Feb 20, 2026 | Feb 19, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 19, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 9, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Jan 29, 2026 | — |
| 4 | Insider transaction | Jan 29, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 14, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Jan 7, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 31, 2025 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Dec 31, 2025 | Dec 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 17, 2025 | Nov 17, 2025 |
| 8-A12B | For registration of certain classes | Nov 17, 2025 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Nov 17, 2025 | Nov 16, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, Other events
|
Oct 24, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Other events
|
Oct 6, 2025 | Sep 30, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 28, 2025 | — |
| S-8 | Employee stock plan registration | Aug 21, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 21, 2025 | Aug 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 23, 2025 | Jul 22, 2025 |
| ARS | Annual report to shareholders | Jul 16, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jul 16, 2025 | Aug 19, 2025 |
| 10-K/A | Amended annual report | Jul 16, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Other events
|
May 21, 2025 | May 21, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 8, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | May 1, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 28, 2025 | Apr 24, 2025 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 3, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 27, 2025 | Feb 22, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 11, 2025 | Feb 7, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Material agreement
|
Jan 22, 2025 | Jan 21, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 17, 2025 | — |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Material agreement
|
Jan 3, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Other events
|
Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 7, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 7, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 7, 2024 |
| 4 | Insider transaction | Nov 8, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 29, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Oct 8, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 26, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Other events
|
Sep 23, 2024 | Sep 20, 2024 |
| SC 13G | Ownership over 5% (passive) | Sep 16, 2024 | — |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Aug 2, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Other events
|
Jun 26, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Other events
|
Jun 24, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 21, 2024 |
| 3 | Initial insider ownership | Jun 21, 2024 | Jun 18, 2024 |
| ARS | Annual report to shareholders | Jun 20, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Jun 20, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 10, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Officer or director change
|
May 13, 2024 | May 10, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Other events
|
May 6, 2024 | May 2, 2024 |
| 4 | Insider transaction | Apr 18, 2024 | Apr 17, 2024 |
| 3 | Initial insider ownership | Apr 2, 2024 | Apr 1, 2024 |
| SC 13D | Ownership over 5% (active) | Mar 22, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 19, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 18, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Mar 18, 2024 | Mar 18, 2024 |
| 424B5 | Prospectus supplement | Mar 18, 2024 | — |
| 10-K | Annual report | Mar 6, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Feb 20, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Jan 30, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 23, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 19, 2024 | Jan 17, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 3 | Initial insider ownership | Jan 2, 2024 | Jan 1, 2024 |
| 8-K |
Current report
Other events
|
Dec 21, 2023 | Dec 21, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2023 | Dec 18, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, Regulation FD disclosure
|
Sep 26, 2023 | Sep 21, 2023 |
| 8-K |
Current report
Other events
|
Sep 13, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 22, 2023 | Aug 17, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement
|
Aug 9, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Other events
|
Aug 7, 2023 | Aug 4, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 13, 2023 | Jul 13, 2023 |
| ARS | Annual report to shareholders | May 31, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | May 31, 2023 | Jul 13, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 26, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 26, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 26, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 26, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 26, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 4 | Insider transaction | May 1, 2023 | May 1, 2023 |
| 3 | Initial insider ownership | May 1, 2023 | May 1, 2023 |
| 8-K |
Current report
Officer or director change
|
May 1, 2023 | May 1, 2023 |
| 4 | Insider transaction | Apr 20, 2023 | Apr 17, 2023 |
| 4 | Insider transaction | Apr 20, 2023 | Apr 17, 2023 |
| 4 | Insider transaction | Apr 20, 2023 | Apr 17, 2023 |
| 4 | Insider transaction | Apr 20, 2023 | Apr 17, 2023 |
| 4 | Insider transaction | Apr 20, 2023 | Apr 17, 2023 |
| 4 | Insider transaction | Apr 20, 2023 | Apr 17, 2023 |
| 4 | Insider transaction | Apr 20, 2023 | Apr 17, 2023 |
| 4 | Insider transaction | Apr 20, 2023 | Apr 17, 2023 |
| 4 | Insider transaction | Apr 4, 2023 | Apr 3, 2023 |
| 4 | Insider transaction | Mar 16, 2023 | Mar 16, 2023 |
| 4 | Insider transaction | Mar 15, 2023 | Mar 14, 2023 |
| 4 | Insider transaction | Mar 15, 2023 | Mar 14, 2023 |
| 4 | Insider transaction | Mar 15, 2023 | Mar 13, 2023 |
| 10-K | Annual report | Mar 6, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 27, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Other events
|
Jan 12, 2023 | Jan 11, 2023 |
| 4 | Insider transaction | Jan 4, 2023 | Jan 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Other events
|
Nov 14, 2022 | Nov 13, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 4 | Insider transaction | Oct 28, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 19, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Other events
|
Sep 13, 2022 | Sep 13, 2022 |
| 8-K |
Current report
Other events
|
Sep 8, 2022 | Sep 1, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 4 | Insider transaction | Aug 10, 2022 | Aug 8, 2022 |
| 4 | Insider transaction | Aug 1, 2022 | Jul 28, 2022 |
| 4 | Insider transaction | Aug 1, 2022 | Jul 28, 2022 |
| 4 | Insider transaction | Aug 1, 2022 | Jul 28, 2022 |
| 4 | Insider transaction | Aug 1, 2022 | Jul 28, 2022 |
| 4 | Insider transaction | Aug 1, 2022 | Jul 28, 2022 |
| 4 | Insider transaction | Aug 1, 2022 | Jul 28, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORMP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1176309
- Former names
- Integrated Security Technologies, Inc. (until Apr 10, 2006); IGUANA VENTURES LTD (until Jun 10, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.